NCT03329664: Autologous Killer Cell Therapy in Colon Cancer Patients |
|
|
| Recruiting | 1/2 | 20 | RoW | Cytokine-induced killer cell, CIK, Chemotherapy AND/OR Radiation Therapy | Sabz Biomedicals, Ministry of Health and Medical Education, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Iran | Colon Cancer Stage IV | 09/21 | 01/22 | | |
NCT04653493: CD19 Targeted CAR T Cell Therapy in Patients With Relapsed/ Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) |
|
|
| Not yet recruiting | 1 | 22 | RoW | CD19 CAR engineered autologous T-cells, Cyclophosphamide, Fludarabine, Mesna | Sabz Biomedicals, Gene Therapy Research Center, Shariati Hospital, Tehran University of Medical Sciences, Iran, Research Institute for Oncology- Hematology and Cell Therapy (RIOHCT), Tehran University of Medical Sciences, Iran | Relapsed B Cell Acute Lymphoblastic Leukemia (ALL), Refractory B Cell Acute Lymphoblastic Leukemia (ALL) | 08/24 | 08/24 | | |
